Current Pain and Headache Reports

, Volume 16, Issue 4, pp 289–291 | Cite as

Complementary Medicine in Cancer Care: Adding a Therapy Dog to the Team

Invited Commentary

Abstract

Animal-assisted therapy, including visits from certified therapy dogs, offer a valuable and often underutilized resource for addressing unmet needs in cancer patients. Prospective research studies have documented symptomatic benefits for reducing pain, psychological distress, and fatigue in a variety of patient populations, including cancer patients. Utilizing consistent policies minimizes patient risk and infection control concerns associated with animal visits.

Keywords

Animal-assisted therapy Anxiety Clostridium difficile Isolation Loneliness Methicillin-resistant Staphylococcus aureus Pain 

References

  1. 1.
    Soothill K, Morris SM, Thomas C, et al. The universal, situational, and personal needs of cancer patients and their main carers. Eur J Oncol Nurs. 2003;7:5–16.PubMedCrossRefGoogle Scholar
  2. 2.
    Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. Epub 2011 Oct 21.Google Scholar
  3. 3.
    Söllner W, Maislinger S, DeVries A, et al. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2000;89:873–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Heese O, Schmidt M, Nickel S, et al. Complementary therapy use in patients with glioma: an observational study. Neurology. 2010;75:2229–35.PubMedCrossRefGoogle Scholar
  5. 5.
    Jia L. Cancer complementary and alternative medicine research at the US National Cancer Institute. Chin J Integr Med. Epub 2012 Jan 12.Google Scholar
  6. 6.
    Marcus DA. Therapy dogs in cancer care: a valuable complementary treatment. New York: Springer; 2012.Google Scholar
  7. 7.
    Coakley AB, Mahoney EK. Creating a therapeutic and healing environment with a pet therapy program. Complement Ther Clin Pract. 2009;15:141–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Marcus DA, Bernstein CD, Constantin JM, Kunkel FA, Breuer P, Hanlon RB. Animal-assisted therapy at an outpatient pain management clinic. Pain Med. 2012;13:45–57.PubMedCrossRefGoogle Scholar
  9. 9.
    Orlandi M, Trangeled K, Mambrini A, et al. Pet therapy effects on oncological day hospital patients undergoing chemotherapy treatment. Anticancer Res. 2007;27:4301–4.PubMedGoogle Scholar
  10. 10.
    Lander DA, Graham-Pole JR. Love medicine for the dying and their caregivers: the body of evidence. J Health Psychol. 2008;13:201–12.PubMedCrossRefGoogle Scholar
  11. 11.
    Bercovitz A, Sengupta M, Jones A, Harris-Kojetin LD. Complementary and alternative therapies in hospice: the National Home and Hospice Care Survey: United States, 2007. Natl Health Stat Rep. 2011;33:1–20.Google Scholar
  12. 12.
    Muschel IJ. Pet therapy with terminal cancer patients. Soc Casework. 1984;65:451–8.PubMedGoogle Scholar
  13. 13.
    LeFebvre SL, Golab GC, Christensen E, et al. Guidelines for animal-assisted interventions in health care facilities. Am J Infect Control. 2008;36:78–85.PubMedCrossRefGoogle Scholar
  14. 14.
    Caprilli S, Messeri A. Animal-assisted activity at A. Meyer Children’s Hospital: a pilot study. Evid Based Complement Alternat Med. 2006;3:379–83.PubMedCrossRefGoogle Scholar
  15. 15.
    Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004;90:2297–304.PubMedGoogle Scholar
  16. 16.
    Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol. 2010;28:4094–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain Behav Immun. 2009;23:10–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Lutgendorf SK, DeGeest K, Dahmoush L, et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun. 2011;25:250–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Block KI. Cost savings with clinical solutions: the impact of reforming health and health care economics with integrative therapies. Integr Cancer Ther. 2010;9:129–35.PubMedCrossRefGoogle Scholar
  20. 20.
    Cangelosi PR, Sorrell JM. Walking for therapy with man’s best friend. J Psychosoc Nurs Ment Health Serv. 2010;48:19–22.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.University of PittsburghPittsburghUSA

Personalised recommendations